Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

por Wolf, I., Waissengrin, B., Zer, A., Bernstein-Molho, R., Rouvinov, K., Cohen, J.E., Cherny, N. I, Bar-Sela, G.
Publicado 2022

The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer

por Waissengrin, B., Zahavi, T., Salmon-Divon, M., Goldberg, A., Wolf, I., Rubinek, T., Winkler, T., Farkash, O., Grinshpun, A., Zubkov, A., Khatib, M., Shachar, S.S., Keren, N., Carmi-Levy, I., Ben-David, U., Sonnenblick, A.
Publicado 2022